Portfolio
Backing Healthcare Innovation
Myosin Therapeutics
Novel therapeutics targeting non-muscle myosin biology for oncology and CNS disease.
PleoPharma
Late-stage development of a pioneering therapy for cannabis withdrawal.
NOXX Therapeutics
Monoclonal antibody therapies that restore immune function in the tumor microenvironment.
ICaPath
Nanoparticle-based immunotherapy delivery for precise, sustained cytokine dosing.
Vycellix
Advancing next-generation NK cell therapies for cancer.
Astrocyte
Small-molecule cerebroprotectants for concussion, traumatic brain injury, and stroke.
Vinci Pharmaceuticals
Sustained-release delivery systems for retinal disease therapy.
NanoRap
Early-stage, pre-clinical research on Rapamycin and aging.
Baylor Genetics
Providing advanced genetic testing and rare disease diagnostics.